News
While public concern is rising over the worsening situation, the Janatha Vimukthi Peramuna/National People’s Power (JVP/NPP) ...
The Food and Drug Administration (FDA) expanded the approval of Moderna’s RSV vaccine late Thursday to include individuals 18-59 years of age who are at increased risk for severe illness from ...
FDA drug alerts in infectious diseases, including new drug approvals, safety warnings, recalls, and changes in indications.
2d
Clinical Trials Arena on MSNBavarian Nordic launches chikungunya vaccine trial for paediatric populationBavarian Nordic has commenced a Phase III trial of its chikungunya vaccine, CHIKV VLP, targeting the paediatric population ...
The United Family of supermarkets is offering a new program to help people prepare for summer travel. It also comes with bonus coupons.
A landmark global modeling study reveals that more than 2.8 billion people in 104 countries are at risk of chikungunya, with ...
The UK’s Medicines and Healthcare products Regulatory Agency said that following global reports of serious adverse events in ...
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
UK's medicine regulator said on Monday it has temporarily restricted the use of French vaccine maker Valneva's shot to treat ...
Poor drainage, stagnant water, uncontrolled waste disposal and tropical humidity are among the leading causes of vector-borne diseases in Mombasa County, amidst a fresh outbreak of Chikungunya.
Valneva reports positive six-month data for Ixchiq in children, supporting a full dose approach ahead of a Phase 3 trial set ...
The feverish diseases dengue and chikungunya could soon become endemic in Europe as the tiger mosquitoes that transmit these viruses spread farther north due to global warming, according to new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results